Volume 7 Issue 244
Published - 14:00 UTC 08:00 EST 2-Sep-2005 
Next Update - 14:00 UTC 08:00 EST 3-Sep-2005

Editor: Susan K. Boyer, RN
All rights reserved.

We subscribe to the HONcode principles. Verify here.



Cochlear implants' performance not affected by amount of hearing loss in the implanted ear

Hearing-impaired individuals with severe to profound hearing loss and poor speech understanding who possess some residual hearing in one ear may experience significant communication benefit from a cochlear implant even if it is placed in the worse-hearing ear, a Johns Hopkins study suggests. more  

Institute of Medicine news: Quarantine stations at ports of entry

The system for intercepting microbial threats at the nation's airports, seaports, and borders needs strategic leadership and a comprehensive plan to meet the challenges posed by emerging diseases and bioterrorist threats, says a new report from the Institute of Medicine of the National Academies. more

Jefferson researchers find chemotherapy and radiation together may be better for patients with locally advanced lung cancer

While researchers have learned in the last decade that combining chemotherapy with radiation is better than radiation alone for treating non-small cell lung cancer patients with locally advanced disease cancer confined to the lungs finding the right combination of drugs and the best timing of treatment has been tricky. more  

Mayo Clinic research shows promise for myeloma patients

Mayo Clinic Cancer Center investigators report that combination therapy with lenalidomide (RevlimidTM) and dexamethasone (combination is called Rev/Dex) looks like a breakthrough treatment for multiple myeloma. Results of a Phase II clinical trial were published online Aug. 23 in Blood. more

Study holds promise for new way to fight HIV 

Researchers have confirmed for the first time the benefit of an innate defense system present in the few patients who remain healthy after years of infection with HIV despite receiving no treatment, according to an article published in the September edition of the Journal of Virology. The study found that the subset of HIV-infected patients referred to as long-term survivors or nonprogressors have higher amounts of a key enzyme in their white blood cells. At the same time, a related biotech company is poised to begin preclinical testing on a drug designed to confer similar protection on most HIV patients. more

Potential ovarian cancer oncogene offers possibility of predictive test and a novel therapy  

Release of the neurotransmitter GABA by adult neuronal precursor cells that develop into neurons limits stem cell proliferation, according to a study at Yale School of Medicine in the September issue of Nature Neuroscience. more

Most chronic hepatitis C sufferers will develop cirrhosis in later life

Nearly 80 percent of chronic hepatitis C sufferers who have the disease for several decades will develop cirrhosis or end-stage liver disease later in life, according to a study published today in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology. Researchers found that it is highly likely that people who are infected with hepatitis C (HCV) for more than 60 years will develop cirrhosis--the highest rate of hepatitis C-associated cirrhosis reported to date. more


Read Vidyya's Hurricane Resources Issue